973 related articles for article (PubMed ID: 30563498)
1. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
[TBL] [Abstract][Full Text] [Related]
2. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
Hariraj V; Aziz Z
Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
[TBL] [Abstract][Full Text] [Related]
3. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
4. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Matos C; van Hunsel F; Joaquim J
Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
Adisa R; Adeniyi OR; Fakeye TO
Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
9. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
Jarernsiripornkul N; Patsuree A; Krska J
Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
[TBL] [Abstract][Full Text] [Related]
10. Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
Yawson AA; Abekah-Nkrumah G; Okai GA; Ofori CG
Ther Adv Drug Saf; 2022; 13():20420986221116468. PubMed ID: 35966898
[TBL] [Abstract][Full Text] [Related]
11. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
Sabblah GT; Darko DM; Mogtari H; Härmark L; van Puijenbroek E
Drug Saf; 2017 Oct; 40(10):911-921. PubMed ID: 28653291
[TBL] [Abstract][Full Text] [Related]
12. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
[TBL] [Abstract][Full Text] [Related]
13. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.
van Hunsel F; van der Welle C; Passier A; van Puijenbroek E; van Grootheest K
Eur J Clin Pharmacol; 2010 Nov; 66(11):1143-50. PubMed ID: 20658130
[TBL] [Abstract][Full Text] [Related]
14. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
15. Patients' experiences on adverse drug reactions reporting: a qualitative study.
Al Dweik R; Yaya S; Stacey D; Kohen D
Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571
[TBL] [Abstract][Full Text] [Related]
16. Parental reporting of adverse drug reactions in South Africa: An online survey.
Pillay S; Mulubwa M; Viljoen M
Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
[TBL] [Abstract][Full Text] [Related]
17. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
[TBL] [Abstract][Full Text] [Related]
18. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
[TBL] [Abstract][Full Text] [Related]
19. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.
Mulchandani R; Kakkar AK
Int J Risk Saf Med; 2019; 30(1):33-44. PubMed ID: 30175985
[TBL] [Abstract][Full Text] [Related]
20. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]